Entrepreneurs First reposted this
The hair-loss industry has a transparency problem. For decades, the market has been flooded with "miracle" products, unproven red lights, and aggressive marketing making unfounded claims. When I founded niostem, based on research I did at the Max Planck Institute for Biology of Ageing, I decided I would not play that game. I believe that when it comes to regenerative medicine, you cannot substitute peer-reviewed science with good marketing. That is why we took the hardest, most expensive route possible for a startup: A randomized, double-blind, sham-controlled trial. Today, I am incredibly proud to announce that our 24-week study on 81 men with Androgenetic Alopecia has been published in Dermatology and Therapy (Springer Nature). The clinical data over 6 months showed: 🔵 +24.40 hairs/cm² increase in total hair density compared to the sham. 🔵 +17.06 hairs/cm² increase in terminal (thicker) hair density. 🔵 A significant +26.24 percentage point difference in cumulative hair thickness. 💙 Zero serious adverse events. We are here to unlock the body’s regenerative potential, and we now have the gold-standard clinical proof that our Stem Cell Reactivation Technology works. I’ve linked the independent coverage by Dermatology Times and the PubMed article in the comments below. I’d love to hear from other health-tech founders: why do you think so few consumer wellness brands invest in double-blind RCTs? None of this would have been possible without the relentless dedication of the niostem team through the years Christophe Ramstein, Gleb Pogorelov, Emil Aliev, Muhammad Jahanzeb Tariq, Adeel Arshad, Timothy Perchey, Mohammad Talha Nahid, and all former team members. A special thank you to our big supporters at Entrepreneurs First, BVP (Brightlands Venture Partners), Luc Starmans, Marcel Kloosterman, Gerhard Schaller, Robby Schwertner [CryptoRobby]🦋, Gerald Neumair, Gerald Steger, Wolfgang Schreiber, Axel Nemetz, August Macke, Sebastian Garcia Dennemark, Nils Sonnenfroh for backing a science-first approach, and to the incredible team at Dermatest GmbH, including Tanja Emmler and Werner Voss, for their rigorous independent clinical execution. #HealthTech #RegenerativeMedicine #StemCells #Alopecia #niostem